Anzeige
Mehr »
Login
Mittwoch, 01.12.2021 Börsentäglich über 12.000 News von 683 internationalen Medien
Kursrallye: Neubewertung im Turbobooster – Meilenstein erwartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DU8Q ISIN: CA74141E1043 Ticker-Symbol: 18H 
Tradegate
30.11.21
21:36 Uhr
0,020 Euro
-0,001
-3,85 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
PREVECEUTICAL MEDICAL INC Chart 1 Jahr
5-Tage-Chart
PREVECEUTICAL MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0200,02310:19
0,0200,02308:00

Aktuelle News zur PREVECEUTICAL MEDICAL Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoPreveceutical Medical Inc: Preveceutical files international patent application8
PREVECEUTICAL MEDICAL Aktie jetzt für 0€ handeln
MoPreveCeutical Medical Inc.: PreveCeutical Files International Patent Application for Sol-Gel Cannabinoid Formulation for Antiviral Use107Vancouver, British Columbia--(Newsfile Corp. - November 29, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce it has...
► Artikel lesen
24.11.Preveceutical Medical Inc: Preveceutical files for Australian acid peptide patent3
24.11.PreveCeutical Medical Inc.: PreveCeutical Files Provisional Patent Application for D-Amino Acid Peptides167Vancouver, British Columbia--(Newsfile Corp. - November 24, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce it has...
► Artikel lesen
18.11.Preveceutical Medical Inc: Preveceutical to license Sol-Gel from UniQuest2
18.11.PreveCeutical Medical Inc.: PreveCeutical Signs License Agreement for Exclusive Rights to Use UniQuest's Sol-Gel Technology for Delivery of Cannabinoids170Vancouver, British Columbia--(Newsfile Corp. - November 18, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), is pleased to announce that...
► Artikel lesen
05.10.Preveceutical Medical Inc: Preveceutical appoints MacCallum as senior adviser9
31.08.Preveceutical Medical Inc: Preveceutical receives $315,338 (Australian) rebate5
31.08.PreveCeutical Medical Inc.: PreveCeutical Receives AU$315,338 Research & Development Tax Incentive Cash Refund420Vancouver, British Columbia--(Newsfile Corp. - August 31, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that it...
► Artikel lesen
07.07.Preveceutical Medical Inc: Preveceutical files int'l patent for dynorphin peptides14
07.07.PreveCeutical Medical Inc.: PreveCeutical Files International Patent Application for its Dynorphin Peptides256Vancouver, British Columbia--(Newsfile Corp. - July 7, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce it has filed...
► Artikel lesen
31.05.PreveCeutical Medical Inc.: PreveCeutical Provides Corporate Update371Vancouver, British Columbia--(Newsfile Corp. - May 31, 2021) - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is pleased to provide the following...
► Artikel lesen
13.03.PreveCeutical Medical Inc.: PreveCeutical Announces Debt Settlement and Conversion of Debt804Vancouver, British Columbia--(Newsfile Corp. - March 12, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that it has agreed to...
► Artikel lesen
23.02.PreveCeutical Medical Inc.: Accomplished Biophysicist Linnéa Olofsson, Ph.D. joins PreveCeutical355Vancouver, British Columbia--(Newsfile Corp. - February 23, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is very pleased to announce...
► Artikel lesen
05.01.PreveCeutical Medical Inc.: PreveCeutical files Provisional Patent Application for its BSV Peptide567Vancouver, British Columbia--(Newsfile Corp. - January 5, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce it has...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1